USUSDSep 28, 23:00
Allogene Therapeutics Inc ALLO
About TRY 79.87 · converted at USD/TRY 49.0003, September 29, 2026, 15:27
- Volume
- 5M
- Day range
- 1.60 – 1.67
- Previous close
- 1.65
- Market cap
- USD 563.2M
Key Data
- Market cap
- USD 563.2M
- EPS
- USD −0.66
- 52 weeks
- 1.053.06
- Day range
- 1.601.67
- 1-year return
- 32.52%
- Previous close
- 1.65
- Open
- 1.65
- Volume
- 5M
- Avg. volume (200d)
- 7.4M
- Sector
- Healthcare
- Industry
- Biotechnology
Technical Signals
Technical signals
Only our Plus members can access this area.
AI Models
AI models
Only our Plus members can access this area.
About Allogene Therapeutics Inc
Allogene Therapeutics Inc (ALLO) last traded at 1.63 USD on the US stock market, a daily move of −1.21%. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 15:27, this price equals about TRY 79.87; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 563.2M USD, earnings per share −0.66 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry. The 52-week range is 1.05 – 3.06 USD; the one-year return is 32.52%.
Frequently Asked Questions
What is the ALLO stock price today?
Allogene Therapeutics Inc (ALLO) last traded at 1.63 USD, a daily change of −1.21%. Prices are delayed by at least 15 minutes.
How much is Allogene Therapeutics Inc (ALLO) stock in Turkish lira?
The last price of Allogene Therapeutics Inc (ALLO) is USD 1.63. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 15:27, that is about TRY 79.87. The conversion is for information only; trades use the exchange rate and fees your broker applies.
How can I buy US stocks from Türkiye?
US stocks such as Allogene Therapeutics Inc (ALLO) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.
What are the P/E ratio and market cap of ALLO?
ALLO trades at a price-to-earnings ratio of —, with earnings per share of −0.66 USD and a market capitalization of 563.2M USD. Ratios use the latest reported results and the current price.
What is the 52-week range of ALLO?
Over the past 52 weeks ALLO traded between 1.05 and 3.06 USD; the one-year return is 32.52%.
Does ALLO pay a dividend?
The current dividend yield of ALLO is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.
What sector is Allogene Therapeutics Inc in?
Allogene Therapeutics Inc (ALLO) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.
Where does the data on this page come from and how fresh is it?
Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.